| UHC Medicare Advantage | Cardiovascular Diagnostic and Therapeutic Procedures – Medicare Advantage Medical Policy | 2026-02-01 |
| UHC Medicare Advantage | Category III CPT Codes – Medicare Advantage Medical Policy | 2026-02-01 |
| UHC Medicare Advantage | Clinical Diagnostic Laboratory Services – Medicare Advantage Medical Policy | 2026-02-01 |
| UHC Medicare Advantage | Molecular Pathology/Genetic Testing Reported with Unlisted Codes – Medicare Advantage Medical Policy | 2026-02-01 |
| UHC Medicare Advantage | Omnibus Codes – Medicare Advantage Medical Policy | 2026-02-01 |
| UHC Medicare Advantage | Skin Substitutes Grafts/Cellular and Tissue-Based Products (Injections and/or Applications) – Medicare Advantage Medical Policy | 2026-02-01 |
| UHC Medicare Advantage | Tier 2 Molecular Pathology Procedures – Medicare Advantage Medical Policy | 2026-02-01 |
| UHC Medicare Advantage | Treatment of Temporomandibular Joint (TMJ) – Medicare Advantage Medical Policy | 2026-02-01 |
| UHC UMR Medical and Drug | Ablative Treatment for Spinal Pain – Commercial and Individual Exchange Medical Policy | 2026-02-01 |
| UHC UMR Medical and Drug | Breast Imaging for Screening and Diagnosing Cancer – Commercial and Individual Exchange Medical Policy | 2026-02-01 |